首页> 外文期刊>JAMA: the Journal of the American Medical Association >Antibiotic prescribing for adults with acute bronchitis in the United States, 1996-2010
【24h】

Antibiotic prescribing for adults with acute bronchitis in the United States, 1996-2010

机译:美国1996-2010年成人急性支气管炎的抗生素处方

获取原文
获取原文并翻译 | 示例
       

摘要

Acute bronchitis is a cough-predominant acute respiratory illness of less than 3 weeks' duration. For more than 40 years, trials have shown that antibiotics are not effective for acute bronchitis.1 Despite this, between 1980 and 1999, the rate of antibiotic prescribing for acute bronchitis was between 60% and 80% in the United States.2 During the past 15 years, the Centers for Disease Control and Prevention (CDC) has led efforts to decrease antibiotic prescribing for acute bronchitis.3'4 Since 2005, a Healthcare Effectiveness Data and Information Set (HEDIS) measure has stated that the antibiotic prescribing rate for acute bronchitis should be zero.To estimate the association with ongoing CDC efforts and the implementation of the HEDIS measure, we evaluated the change in antibiotic prescribing rates for acute bronchitis in the United States between 1996 and 2010.
机译:急性支气管炎是一种以咳嗽为主的急性呼吸道疾病,病程少于3周。 40多年来,试验表明,抗生素对急性支气管炎无效。1尽管如此,在1980年至1999年之间,在美国,急性支气管炎的抗生素处方率在60%至80%之间。2在过去的15年中,疾病控制和预防中心(CDC)一直在努力减少急性支气管炎的抗生素处方。3'4自2005年以来,医疗保健有效性数据和信息集(HEDIS)措施已表明,急性支气管炎应为零。为了评估与疾病预防控制中心正在进行的工作和HEDIS措施的实施之间的关系,我们评估了1996年至2010年美国急性支气管炎的抗生素处方率变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号